Valerie Pierce
Compliance Officer bei NGM BIOPHARMACEUTICALS, INC.
Profil
Valerie L.
Pierce is currently working as the Senior Vice President & Associate General Counsel at Jazz Pharmaceuticals, Inc. since 2012.
She is also currently serving as the Secretary, Chief Compliance Officer & Senior VP at NGM Biopharmaceuticals, Inc. since 2019.
Previously, Valerie worked as the Senior Corporate Counsel at ALZA Corp.
from 1995 to 2000.
She then served as the Assistant General Counsel at Tularik, Inc. from 2000 to 2004.
In 2007, she held the position of Secretary, Senior Vice President & General Counsel at Sunesis Pharmaceuticals, Inc. until 2008.
Valerie also worked as the Vice President & Senior Transactional Counsel at Amyris, Inc. Additionally, she served as the General Counsel at PATH Drug Solutions from 2005 to 2006.
Ms. Pierce completed her undergraduate degree at Yale University and obtained her graduate degree from Yale Law School.
Aktive Positionen von Valerie Pierce
| Unternehmen | Position | Beginn |
|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Compliance Officer | 29.10.2019 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | 01.01.2012 |
Ehemalige bekannte Positionen von Valerie Pierce
| Unternehmen | Position | Ende |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | General Counsel | 06.06.2008 |
| PATH Drug Solutions | General Counsel | 01.01.2006 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.2004 |
| ALZA CORPORATION | General Counsel | 01.01.2000 |
| AMYRIS, INC. | Corporate Officer/Principal | - |
Ausbildung von Valerie Pierce
| Yale University | Undergraduate Degree |
| Yale Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMYRIS, INC. | Process Industries |
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
| PATH Drug Solutions | Commercial Services |
